Dow AgroSciences LLC and Schillinger Seed, Inc. have entered into a licensing, research, and development agreement for the commercialization of transgenic commodity soybeans.
“We are pleased to be working with Schillinger. This is one more step to expand the soybean genetic platform for Dow AgroSciences, and will expand the soybean platform for Dow AgroSciences to launch its Dow Herbicide Tolerance (DHT) trait,” says Jerome Peribere, Dow AgroSciences president and CEO. “Furthermore, this collaboration will help accelerate the development and launch of future traits in soybeans.”
Under the agreement, Dow AgroSciences will obtain the Schillinger Seed brand and exclusive right to breed, produce, distribute, and sell Schillinger Seed brand transgenic commodity soybeans. In addition, Schillinger will continue to develop and produce proprietary soybean germplasm for Dow AgroSciences to use in breeding and commercial sales.
Non-genetically modified and specialty soybeans will continue to be researched, developed, and marketed independently by Schillinger under its recently introduced eMerge Genetics brand.
Dow AgroSciences will continue to sell Schillinger Seed transgenic soybean seed through Stratton Seed of Stuttgart, AR, in the Southern U.S. Additional terms of the agreement were not disclosed.